Company Filing History:
Years Active: 2015-2021
Title: The Innovations of Stephen Michael Frazer Jamieson
Introduction
Stephen Michael Frazer Jamieson is a notable inventor based in Auckland, New Zealand. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of kinase inhibitors. With a total of 2 patents to his name, Jamieson's work focuses on innovative compounds that have the potential to treat various diseases.
Latest Patents
Jamieson's latest patents include "Tricyclic heterocyclic derivatives and uses thereof" and "Kinase inhibitors, prodrug forms thereof and their use in therapy." The first patent discloses tricyclic heterocyclic compounds that exhibit kinase inhibitory activity. These compounds are particularly useful in the treatment of diseases mediated by CSF-1R, including cancers and autoimmune conditions. The second patent provides details on kinase inhibitors and their prodrug forms, emphasizing their therapeutic applications, especially in cancer treatment.
Career Highlights
Jamieson is associated with Auckland Uniservices Limited, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on medical therapies and drug development.
Collaborations
Some of his notable coworkers include Guo-Liang Lu and William Alexander Denny. Their collaborative efforts contribute to the innovative research environment at Auckland Uniservices Limited.
Conclusion
Stephen Michael Frazer Jamieson is a prominent figure in the field of pharmaceutical innovation, with a focus on developing effective treatments for serious medical conditions. His contributions through his patents reflect a commitment to advancing healthcare solutions.